Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06353243 · ClinicalTrials.gov registry record · NA

Bilateral Infant Stimulation Study

A NA study of Preterm Birth and Parent-Child Relations, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06353243: Recruiting NA study of Preterm Birth and Parent-Child Relations, sponsored by Oregon Health and Science University.

NCT06353243 is a NA study of Preterm Birth and Parent-Child Relations that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 40 participants, below the 4,408-participant average among 39 other Preterm Birth trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06353243, a NA study of Preterm Birth and Parent-Child Relations, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study will investigate stress that parents of children admitted to the neonatal intensive care unit (NICU) experience. Investigation of a novel intervention of using bilateral alternating stimulation to reduce parental stress and anxiety and increase bonding/attachment in NICU. Evaluate parental stress and feelings of bonding using surveys before and after the intervention. Intervention will be done at neonate's bedside while admitted to the NICU. Vital sign data will be collected as a marker of parent and neonate's stress response during the intervention.

Conditions Studied

Preterm Birth Parent-Child Relations Stress Reaction Hospitalism in Children

Interventions

  • BEHAVIORAL Bilateral alternating stimulation

Study Locations (1)

Oregon

  • Oregon Health and Science University Neonatal Intensive Care Unit - Portland

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-02-26
Est. Completion 2024-08
Phase NA
Oregon Health and Science University

546 total trials

What NCT06353243 shows while recruiting

NCT06353243 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 4,408-participant average among 39 other Preterm Birth trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which Bilateral alternating stimulation is the first listed.

NCT06353243 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT06353243 about?

NCT06353243 is a clinical study titled "Bilateral Infant Stimulation Study". This study will investigate stress that parents of children admitted to the neonatal intensive care unit (NICU) experience. Investigation of a novel intervention of using bilateral alternating stimulation to reduce parental stress and anxiety and increase bonding/attachment in NICU. Evaluate parenta...

What is the current status of trial NCT06353243?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-02-26. Estimated completion is 2024-08.

What conditions does trial NCT06353243 study?

This clinical trial studies the following conditions: Preterm Birth, Parent-Child Relations, Stress Reaction, Hospitalism in Children.

What interventions are being tested in trial NCT06353243?

The interventions under investigation include: Bilateral alternating stimulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06353243?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06353243 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06353243's enrollment target sits among peer trials

40 34th of 39 higher than 4 of 39 other Preterm Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06353243

Source: ClinicalTrials.gov NCT06353243, the US trial registry maintained by the National Library of Medicine. NCT06353243 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.